Protalix Biotherapeutics, Inc. (NYSE American:PLX)
About the company
Protalix Biotherapeutics, Inc. engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa and OPRX-106. The company was by Yoseph Shaaltiel in 1993 and is headquartered in Karmiel, Israel.
Gross Margin (in %)
Operating Margin (in %)
Net Margin (in %)
Dividend Yield (in %)
|Name||Ticker||Market capitalization (in USD Million)||Revenues (in USD Million)||Price/Book||Price/Earning||Net margin (in %)|
|IQVIA Holdings, Inc.||IQV||28020.96||11158.00||4.88||129.83||1.93|
|Laboratory Corp. of America Holdings||LH||16686.46||11587.00||2.36||52.88||2.77|
|Quest Diagnostics, Inc.||DGX||15781.44||7726.00||2.74||18.48||10.33|
|Syneos Health, Inc.||SYNH||6098.18||4720.00||2.01||30.93||4.13|
|National Research Corp.||NRC||1517.10||130.00||39.43||41.68||27.51|
|Apollo Medical Holdings, Inc.||AMEH||591.12||625.00||2.96||32.84||2.89|
|Bioanalytical Systems, Inc.||BASI||57.64||55.00||5.76||-24.95||-3.94|
|Protalix Biotherapeutics, Inc.||PLX||55.95||66.00||-3.93||-5.92||-14.18|
|Interpace Biosciences, Inc.||IDXG||24.56||24.00||1.91||-0.85||-112.78|
|Pressure BioSciences, Inc.||PBIO||4.50||2.00||-0.52||-0.28||-876.69|
Latest insider transactions
|Date||Role||Name||Transaction||Quantity||Quantity Owned After|
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...
Protalix BioTherapeutics, Inc. PLX and its Italian partner Chiesi Farmaceutici S.p.A. announced that they have successfully completed a type B pre-Biologics License Application (“BLA”) meeting ...
Protalix BioTherapeutics Appoints Yael Hayon, Ph.D. as its New Vice President, Research and Development
CARMIEL, Israel, June 8, 2020 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX) today announced the appointment of Yael Hayon, Ph.D. as the Company's new Vice ...
Before it's here, it's on the Bloomberg Terminal.
These stocks are Catalyst Biosciences Inc (NASDAQ:CBIO), Gulfport Energy Corporation (NASDAQ:GPOR), Navios Maritime Acquisition Corp (NYSE:NNA), and Protalix BioTherapeutics Inc. (NYSE:PLX).
Protalix Biotherapeutics, Inc. engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include ...